These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2932060)
1. [A comparative study of 5'-DFUR and tegafur in recurrent breast cancer]. Taguchi T; Terasawa T; Abe O; Yoshida Y; Tominaga T; Ogawa N Gan To Kagaku Ryoho; 1985 Oct; 12(10):2052-60. PubMed ID: 2932060 [TBL] [Abstract][Full Text] [Related]
2. [Clinical trial of 5'-DFUR in patients with recurrent breast cancer]. Morimoto T; Komaki K; Yamakawa T; Tanaka T; Konishi Y; Uomine Y; Miki H; Ooshimo K; Monden Y Gan To Kagaku Ryoho; 1988 Oct; 15(10):2983-9. PubMed ID: 2972258 [TBL] [Abstract][Full Text] [Related]
3. [Phase II study of 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with malignant cancer--a multi-institutional cooperative study]. Niitani H; Kimura K; Saito T; Nakao I; Abe O; Urushizaki I; Ohta K; Yoshida Y; Kimura T; Kurihara M Gan To Kagaku Ryoho; 1985 Oct; 12(10):2044-51. PubMed ID: 2932059 [TBL] [Abstract][Full Text] [Related]
4. [Phase II study of 5'-DFUR treatment of the bladder and prostatic cancer]. Ohmori H; Matsumura Y; Ochi J; Kobashi K; Akebi N; Saika T; Nanba K; Tanahashi T; Josen T; Nasu Y Gan To Kagaku Ryoho; 1991 Oct; 18(13):2307-14. PubMed ID: 1834024 [TBL] [Abstract][Full Text] [Related]
5. [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group]. Taguchi T; Sakai K; Terasawa T; Irie K; Okajima K; Yamamoto M; Kawahara T; Satomi T; Tomita K; Yamaguchi A Gan To Kagaku Ryoho; 1985 Nov; 12(11):2179-84. PubMed ID: 2933001 [TBL] [Abstract][Full Text] [Related]
6. [Phase II study of 5'-DFUR in gastrointestinal and breast cancer]. Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G Gan To Kagaku Ryoho; 1985 Nov; 12(11):2172-8. PubMed ID: 2933000 [TBL] [Abstract][Full Text] [Related]
7. [A new anticancer drug, 5'-deoxy-5-fluorouridine (5'-DFUR)]. Tsukagoshi S Gan To Kagaku Ryoho; 1987 Oct; 14(10):2977-82. PubMed ID: 2959207 [TBL] [Abstract][Full Text] [Related]
8. [Usefulness of low dose 5'-DFUR (5'-deoxy-5-fluorouridine) for advanced or recurrent breast cancer]. Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S Gan To Kagaku Ryoho; 1999 Jun; 26(7):951-8. PubMed ID: 10396323 [TBL] [Abstract][Full Text] [Related]
9. [Phase II study of 5'-DFUR (Furtulon) capsule for bladder cancer]. Kubota Y; Miura T; Shuin T; Kinoshita Y; Hosaka M; Kondo I; Moriyama M; Fukushima S; Fukuoka H; Miyai K Gan To Kagaku Ryoho; 1991 Oct; 18(13):2301-6. PubMed ID: 1834023 [TBL] [Abstract][Full Text] [Related]
10. [Clinical trial of 5'-deoxy-5-fluorouridine (5'-DFUR) in advanced cancer patients]. Irie K; Yasutake K; Imamura Y; Yoshimura Y; Yoshida M; Nakamura T; Suehiro I Gan To Kagaku Ryoho; 1985 Dec; 12(12):2371-8. PubMed ID: 2934026 [TBL] [Abstract][Full Text] [Related]
11. [Combination therapy of doxifluridine (5'-DFUR) + cyclophosphamide (CPA) + tamoxifen (TAM) for advanced or recurrent breast cancer. Joint Research Group in the Osaka Area for Combination Therapy of 5'-DFUR with Other Drugs]. Ota J; Taguchi T; Sakai K; Irie K; Terasawa T; Shimoyama T; Kawahara T; Okumura T; Yamamoto M; Yasutake K Gan To Kagaku Ryoho; 1992 Aug; 19(9):1279-84. PubMed ID: 1386974 [TBL] [Abstract][Full Text] [Related]
12. Phase II study of oral administration of 5'-deoxy-5-fluorouridine (5'-DFUR) for solid tumors. Shimizu E; Saijo N; Eguchi K; Shinkai T; Tominaga K; Sasaki Y; Fujita J; Nomori H; Hoshi A Jpn J Clin Oncol; 1984 Dec; 14(4):679-83. PubMed ID: 6240546 [TBL] [Abstract][Full Text] [Related]
13. [Clinical effect of 5'-deoxy-5-fluorouridine (5'-DFUR)]. Nakano Y; Ohota J; Fujita M; Taguchi T Gan No Rinsho; 1985 May; 31(6 Suppl):746-50. PubMed ID: 3162050 [TBL] [Abstract][Full Text] [Related]
14. [Co-operative clinical evaluation of 5'-DFUR tablets for breast cancer at 31 institutions]. Morimoto K; Taguchi T; Ohta J; Miura S; Ueda N; Yayoi K; Inaji H Gan To Kagaku Ryoho; 1992 Jul; 19(7):1041-8. PubMed ID: 1385688 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of weekly paclitaxel and doxifluridine (5'-DFUR) combination therapy in patients with advanced or recurrent breast cancer]. Okamoto Y; Tominaga T; Okuyama N; Sawada T; Kou Y Gan To Kagaku Ryoho; 2003 May; 30(5):661-7. PubMed ID: 12795098 [TBL] [Abstract][Full Text] [Related]
16. [Comparative study on two different types of tegafur for recurrent breast cancer]. Taguchi T Gan To Kagaku Ryoho; 1984 Feb; 11(2):312-8. PubMed ID: 6421249 [TBL] [Abstract][Full Text] [Related]
17. [Effects of 5'-deoxy-5-fluorouridine on human gastrointestinal and breast cancers xenografted to nude mice]. Fujita F; Fujita M; Taguchi T Gan To Kagaku Ryoho; 1984 Aug; 11(8):1635-43. PubMed ID: 6236751 [TBL] [Abstract][Full Text] [Related]
18. [A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer]. Saeki T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Taguchi T Gan To Kagaku Ryoho; 2004 Apr; 31(4):539-47. PubMed ID: 15114697 [TBL] [Abstract][Full Text] [Related]
19. [Clinical trial of a new fluorinated pyrimidine, 5'-deoxy-5-fluorouridine (5'-DFUR)]. Hoshino A; Ohara K; Kamiya O; Nagata K; Ono Y; Kawakubo A; Ozaki Y; Suzuki A; Ogasawara T; Sugiura I Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1079-82. PubMed ID: 2938548 [No Abstract] [Full Text] [Related]
20. [Phase I study of 5'-deoxy-5-fluorouridine (5'-DFUR)]. Nakao I; Saito T; Kimura K; Wakui A; Yokoyama M; Kanamaru R; Furue H; Komita T; Ohta K; Murakami M Gan To Kagaku Ryoho; 1985 Oct; 12(10):2037-43. PubMed ID: 2932058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]